Genovac Antibody Discovery Launches in NDSU Research and Technology Park
April 26, 2021 12:59 ET | Source: Genovac Genovac Fargo,
Fargo, North Dakota, April 26, 2021 (GLOBE NEWSWIRE)
Genovac Antibody Discovery has launched in the United States following a management buyout of an antibody discovery business unit owned by Aldevron, a U.S.-based contract manufacturing organization. The unit, which was established and operates in Freiburg, Germany, is now headquartered in Fargo, N.D. Brian Walters, who had been serving as the president of Aldevron’s Antibody Discovery Group, led the management buyout and is now Genovac’s president and CEO. Genovac is a contract research organization that discovers and develops antibodies for therapeutic, diagnostic and research and development market segments, with clients in North America, Europe, Australia and Asia. The company’s core technology, genetic immunization, enables rapi
Monoclonal Antibody Combo Reduces Marburg Disease Risk
precisionvaccinations.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from precisionvaccinations.com Daily Mail and Mail on Sunday newspapers.
Combination therapy protects against advanced Marburg virus disease
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.